期刊文献+

产科成分用血现状调查与用血分析 被引量:6

Survey of the Status of Using Blood Components in Obstetrics
在线阅读 下载PDF
导出
摘要 目的了解某市产科临床成分用血现状和无指征用血原因分析。方法对本市2006年9家医院产科住院患者的输血病例进行回顾性分析。结果查阅输血病例共计400例,接受红细胞(RBC)、血浆、冷沉淀和/或血小板输注(1例患者可能同时输用多种成分)的病例百分比分别为93.3%、35.5%、6.8%和8.0%,各成分血用量分别占总用量的49.5%、25.0%、10.9%和14.6%。合理用血状况的分析显示,各成分输血病例符合指征率分别为64.34%、19.01%、51.85%和81.25%。血浆循证输注的人均用量为23.4 U,而无指征的人均用量仅为2 U。结论产科的临床输血以RBC成分为主,血浆安慰性输注的现象普遍,有待改善。 Objective To survey the status of clinical use of blood components and to analyze the inappropriate reasons in obstetrics in urban area.Methods Four hundred cases who have received transfusion therapies were analyzed through retrospective reviewing medical records of obstetric inpatients from 9 hospitals during 2006 in our city.Results For packed red blood cells(RBC),plasma,cryoprecipitate and/or platelet(one case might have multi-component transfusion during hospitalization),percentages of transfusion therapies respectively reached to 93.3%(373/400),35.5%,6.8% and 0.8% among 400 cases with transfusion records,and usage of the total units accounted for 49.5%(1 697/3 429),25.0%,10.9% and 14.6%.The analysis of appropriate use of blood components showed that 64.34% of RBC,19.01% of plasma,51.85% of cryoprecipitate and 81.25% of platelet were transfused with clinical indications.For plasma with evidence-based transfusion,per case used 23.4 units averagely,but for one without evidence-based only consumed 2 units.Conclusion The transfusion therapies in obstetrics medicine dominantly rely on RBC,but exist a prevailing status of less strict indications in plasma use,which need to be improved in further practice.
机构地区 深圳市血液中心
出处 《临床输血与检验》 CAS 2011年第3期218-221,共4页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 产科 成分血 输血指征 Obstetrics Blood components Transfusion indication
  • 相关文献

参考文献9

  • 1Stainsby D,MacLennan S,Thomas D,et al.Guidelines on the management of massive blood lossBritish Journal of Haematology,2006.
  • 2Wallis JP,GreenS,Avery S,et al.Transfusion,dis-charge haemoglobin,and readmission or death afterhip fractureVox Sanguinis,2010.
  • 3WHO,Department of Blood Safety and Clinical Tech-nology.The clinical use of blood in medicine,obstet-rics,paediatrics,surgery and anaesthesia,trauma andburns,2005.
  • 4Chapman JF,,Bain BJ,Bates SC,et al.The estimationof fetomaternal haemorrhage,1999.
  • 5WHO Department of Making Pregnency Safer.WHORecommendations for the Prevention of PostpartumHaemorrhage,2006.
  • 6Shaughnessy DF,Atterbury C,Bolton Maggs P,et al.Guidelines for the use of fresh-frozen plasma,cryopre-cipitate and cryosupernatantBritish Journal of Haematology,2004.
  • 7杨宝成,孔令魁,邵超鹏,熊文,周丹.2597份临床输血病历用血合理性调查分析[J].中国输血杂志,2008,21(3):193-196. 被引量:120
  • 8Carpani M,Bozzo M,Betto E,et al.Fresh frozon plas-ma in HELLP syndrome:from misuse to appropriateuseVox Sanguinis,2010.
  • 9Bray TJ,Salil P,Weiss HA,et al.Intervention to pro-mote appropriate blood use in India,2002.

二级参考文献9

  • 1刘利明,陈蓉.成分输血不合理现象浅析[J].中国输血杂志,2006,19(6):486-487. 被引量:41
  • 2中华人民共和国卫生部.临床输血技术规范[S].卫医发[2000]184.
  • 3World Health Organization. Blood transfusion safety. The clinical use of blood-handbook [ C ]. Geneva: WHO, 2002.
  • 4American Society of Anesthesiologists. Practice guidelines for perioperative blood transfusion and adjuvant therapies [J]. Anesthesiology, 2006, 105 ( 1 ) : 198-208.
  • 5British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of freshfrozen plasma, cryoprecipitate and cryosupematant [ J ]. Br Soci Haematol, 2004, 126(1 ) : 11-28.
  • 6Marconi M. Italian guidelines for the appropriate use of plasma [J]. Tumori, 2001, 87(2) :14-16.
  • 7Luk C, Eckert KM, Barr RM,et al. Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines [ J ]. CMAJ, 2002, 166(12): 1539-1540.
  • 8Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryprecipitate transfusion in New South Wales public hospital [ J ]. Medi J Am, 2003, 178(3) :117-120.
  • 9张素芬,唐利民.临床输血现状分析[J].中国临床医生杂志,2003,31(11):33-35. 被引量:18

共引文献120

同被引文献54

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部